An improved benefit-risk profile of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who received ≥2 prior therapies

Marco Montillo, Ian Flinn, Matthew Davids, Peter Hillmen, Julio Delgado, Bryone Kuss, Constantine Tam, Ulrich Jager, Paolo Ghia, Stephan Stilgenbauer, Stephanie Lustgarten, David T. Weaver, Hagop Youssoufian, Florence Cymbalista

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'An improved benefit-risk profile of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who received ≥2 prior therapies'. Together they form a unique fingerprint.

Medicine and Dentistry